PEPTIDE
GHK-Cu
Copper Peptide GHK-Cu
$39GHK-Cu is a naturally occurring copper-binding tripeptide first identified in human plasma by Dr. Loren Pickart in 1973. The glycyl-L-histidyl-L-lysine sequence forms a high-affinity complex with copper(II) ions, and has been extensively studied for its role in tissue remodeling, gene expression regulation, and antioxidant defense mechanisms.
Copper Chelation Complex
Forms a stable 1:1 complex with Cu²⁺ ions, enabling copper delivery and bioavailability studies in cellular research models.
Gene Expression Modulation
Research indicates regulation of over 4,000 human genes, with significant effects on collagen synthesis, antioxidant enzymes, and growth factor expression.
Tissue Remodeling Research
Extensively studied for its effects on extracellular matrix (ECM) remodeling, including collagen and glycosaminoglycan synthesis in dermal models.
GHK peptide as a natural modulator of multiple cellular pathways
Comprehensive review of GHK-Cu's gene regulatory activities and potential applications in tissue repair and regeneration research.
| Product Name | GHK-Cu (Copper Peptide) |
| CAS Number | 49557-75-7 |
| Molecular Formula | C₁₄H₂₃CuN₆O₄ |
| Molecular Weight | 403.93 Da |
| Sequence | Gly-His-Lys · Cu²⁺ |
| Purity | ≥99% (HPLC) |
| Physical Form | Blue Lyophilized Powder |
| Storage | -20°C, protected from light and moisture |
| Certification | Third-party HPLC & MS verified |
| Intended Use | Research and laboratory use only |
